Glucagon-like peptide-1 receptor agonists and risk of prostatic cancer: A systematic review and meta-analysis of randomized controlled trials
Year: 2025
Type: review
Abstract: To conduct a meta-analysis of randomized clinical trials (RCTs) to investigate whether there is an association between glucagon-like peptide-1 receptor agonist(GLP-1RA) treatment and prostatic cancer.
Source: Figshare
Author: Huang, Zhilong
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6958535388
FWCI:
Cites:
Cited by:
Related to: